A phase I/II study of albumin-bound rapamycin nanoparticles in the treatment of bacillus calmette-guerin refractory non-muscle invasive transitional cell bladder cancer
| Autor: | Ifeanyi Onyeji, Guarionex Joel DeCastro, Arindam RoyChoudhury, Dara Holder, Sam S. Chang, Danny Lascano, James M. McKiernan, Jennifer Ahn, Cory Abate-Shen, Neil Desai |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Bacillus (shape)
Cancer Research Bladder cancer biology Transitional cell bladder cancer business.industry 030232 urology & nephrology Albumin medicine.disease biology.organism_classification 03 medical and health sciences 0302 clinical medicine Phase i ii Oncology Refractory 030220 oncology & carcinogenesis Cancer research medicine Non muscle invasive business PI3K/AKT/mTOR pathway |
| Zdroj: | Journal of Clinical Oncology. 34:e16008-e16008 |
| ISSN: | 1527-7755 0732-183X |
| Popis: | e16008Background: Up to 40% of patients treated with intravesical agents for non-muscle invasive bladder cancer (NMIBC) will recur. Our lab has previously demonstrated the feasibility of mTOR inhib... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|